summary (IMAGE)
Caption
Neuroendocrine tumors, including small cell lung cancer, are not highly visible to immune cells due to a lack of surface proteins called NKG2DL. A UT Southwestern study found that HDAC inhibitor drugs allow these proteins to be produced, causing tumor cells to be recognized and targeted by immune cells.
Credit
UT Southwestern Medical Center
Usage Restrictions
None
License
Licensed content